Sutro Biopharma, Inc. financial data

Symbol
STRO on Nasdaq
Location
111 Oyster Point Blvd., South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 270 % -36.5%
Debt-to-equity 1.35K % +440%
Return On Equity -853 % -778%
Return On Assets -58.7 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.8M shares +3.43%
Common Stock, Shares, Outstanding 84.7M shares +3.49%
Entity Public Float 238M USD -14.6%
Common Stock, Value, Issued 85K USD +3.66%
Weighted Average Number of Shares Outstanding, Basic 84.6M shares +4.13%
Weighted Average Number of Shares Outstanding, Diluted 84.6M shares +4.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 104M USD -38.3%
Research and Development Expense 223M USD +2.17%
General and Administrative Expense 47M USD -17.8%
Operating Income (Loss) -205M USD -93.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.5M USD +76%
Income Tax Expense (Benefit) -18K USD -325%
Net Income (Loss) Attributable to Parent -209M USD -67.7%
Earnings Per Share, Basic -2 USD/shares -92.5%
Earnings Per Share, Diluted -2 USD/shares -92.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 64M USD -29.5%
Marketable Securities, Current 141M USD -50.5%
Accounts Receivable, after Allowance for Credit Loss, Current 8M USD +15.1%
Assets, Current 232M USD -47.8%
Property, Plant and Equipment, Net 15M USD -22.8%
Operating Lease, Right-of-Use Asset 14.8M USD -27%
Other Assets, Noncurrent 50K USD -99%
Assets 262M USD -46.4%
Accounts Payable, Current 4.31M USD -29.2%
Accrued Liabilities, Current 11.8M USD +18.4%
Contract with Customer, Liability, Current 12M USD -83.8%
Liabilities, Current 74.2M USD -42.9%
Contract with Customer, Liability, Noncurrent 6.91M USD -68.2%
Operating Lease, Liability, Noncurrent 11.5M USD -41.1%
Other Liabilities, Noncurrent 1.69M USD 0%
Liabilities 294M USD -12.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -13K USD +92%
Retained Earnings (Accumulated Deficit) -874M USD -31.4%
Stockholders' Equity Attributable to Parent -32.1M USD -121%
Liabilities and Equity 262M USD -46.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -67.9M USD -4.85%
Net Cash Provided by (Used in) Financing Activities 66K USD
Net Cash Provided by (Used in) Investing Activities -16.3M USD -125%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 84.7M shares +3.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -84.1M USD -1968%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 64.9M USD -29.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 228M USD +35.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 232M USD +28.2%
Operating Lease, Liability 19.6M USD -26.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -209M USD -67.3%
Lessee, Operating Lease, Liability, to be Paid 22.1M USD -29.8%
Property, Plant and Equipment, Gross 66.8M USD +4.24%
Operating Lease, Liability, Current 8.06M USD +16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.29M USD -7.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.99M USD -5.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.54M USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.29M USD -7.84%
Deferred Tax Assets, Operating Loss Carryforwards 39.7M USD +6.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.1M USD +38.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.29M USD -7.84%
Operating Lease, Payments 2.3M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.9M USD +7.89%
Deferred Tax Assets, Net of Valuation Allowance 3.82M USD -70.8%
Share-based Payment Arrangement, Expense 23.3M USD -4.88%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%